PATENT CLAIM ANALYSIS

Application Number: 16062501
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["564", "180000"]

Abstract:
Disclosed herein are inhibitors of TNF superfamily costimulatory interactions, and methods for their use in modulating TNF superfamily costimulatory interactions and treating immune system related disorders. In particular, disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof: wherein the substituents are described herein.

Claim (Index 47):
A method of treating an inflammatory or immune system related disorder in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 34.0
- Percentile: 94.0
- Lexical Diversity: 1.35
- Patent Class: 564.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11914714', '12891447', '10574612', '14327448', '14844652']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6420104876424126
- 35 USC 102 Novelty (BERT): 0.5089275503682765
- Combined Prediction Score: 0.628702193914999
- Mean Citation Score: 164.399156
- Max Citation Score: 167.3293
- Similarity Product: 114.92880511471031

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test